You are in:Home/Publications/BIOMARKER FOR METASTASIZED CANCER EXPERIMENTALLYINDUCED IN MICE

Prof. Yakout A. Elsenosi :: Publications:

Title:
BIOMARKER FOR METASTASIZED CANCER EXPERIMENTALLYINDUCED IN MICE
Authors: Metwally k. mahfouzea, Hosny A. Hassanb, Hussein A. Alic, Yakout A. El-SenosicMohamed A. Abd EL-Azizd,
Year: 2013
Keywords: HCC, Gal-3, AST/ ALT ratio.
Journal: BENHA VETERINARY MEDICAL JOURNAL
Volume: 24
Issue: 1
Pages: Not Available
Publisher: BENHA VETERINARY MEDICAL JOURNAL
Local/International: International
Paper Link:
Full paper Not Available
Supplementary materials Not Available
Abstract:

Hepatocellular carcinoma (HCC) is the third most frequent cause of cancer death worldwide,with an estimated mortality rate of about one million deaths annually. Galectin-3 is widely spreadamong different types of cells and tissues, galectin-3 also found intracellularly in nucleus andcytoplasm. Galectin-3 affects numerous biological processes and seems to be involved in differentphysiological and pathophysiological conditions, such as development, immune reactions, andneoplastic transformation and metastasis. In this study, we found over expression of galectin-3 proteinand mRNA, in HCC tissue compared with normal liver tissue. In addition, we found expression ofgalectin-3 in the nuclear protein fraction. The overexpression of galectin-3 was accompanied withelevated levels of serum nitrite and aminotransferases (AST and ALT). Conclusion: Galectin-3 mightbe a potential therapeutic target for the prevention and treatment of hepatocellular carcinoma.Moreover, the nucleo/cytoplasmic shuttling of gal-3 might play a role in inhibition and/or regulationof gene expression related to cancer.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus